Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1.
Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1. Blood. 2016 06 02; 127(22):2693-700.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Dexamethasone
Female
Humans
Lactones
Male
Maximum Tolerated Dose
Middle Aged
Multiple Myeloma
Pyrroles
Recurrence
Thalidomide
authors with profiles
Andrzej Jakubowiak